Sichuan Hebang Biotechnology Corporation Limited
603077.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | CN¥6,821 | CN¥6,864 | CN¥7,120 | CN¥6,999 |
| Short-Term Investments | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Receivables | CN¥1,807 | CN¥1,789 | CN¥1,708 | CN¥2,073 |
| Inventory | CN¥4,060 | CN¥4,241 | CN¥4,665 | CN¥4,545 |
| Other Curr. Assets | CN¥154 | CN¥145 | CN¥188 | CN¥181 |
| Total Curr. Assets | CN¥13,074 | CN¥13,194 | CN¥13,875 | CN¥14,003 |
| Property Plant & Equip (Net) | CN¥9,904 | CN¥11,816 | CN¥9,961 | CN¥9,952 |
| Goodwill | CN¥1,838 | CN¥1,838 | CN¥1,838 | CN¥1,838 |
| Intangibles | CN¥2,887 | CN¥1,031 | CN¥2,834 | CN¥2,562 |
| Long-Term Investments | CN¥1,004 | CN¥819 | CN¥0 | CN¥0 |
| Tax Assets | CN¥135 | CN¥141 | CN¥128 | CN¥127 |
| Other NC Assets | CN¥450 | CN¥384 | CN¥1,208 | CN¥1,167 |
| Total NC Assets | CN¥16,220 | CN¥16,030 | CN¥15,969 | CN¥15,646 |
| Other Assets | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total Assets | CN¥29,294 | CN¥29,223 | CN¥29,845 | CN¥29,650 |
| Liabilities | – | – | – | – |
| Payables | CN¥984 | CN¥1,225 | CN¥1,370 | CN¥2,108 |
| Short-Term Debt | CN¥2,986 | CN¥2,341 | CN¥2,518 | CN¥2,353 |
| Tax Payable | CN¥0 | CN¥63 | CN¥55 | CN¥35 |
| Deferred Revenue | CN¥149 | CN¥0 | CN¥0 | CN¥0 |
| Other Curr. Liab. | CN¥38 | CN¥563 | CN¥902 | CN¥802 |
| Total Curr. Liab. | CN¥4,265 | CN¥4,267 | CN¥4,923 | CN¥5,375 |
| LT Debt | CN¥5,932 | CN¥5,882 | CN¥5,865 | CN¥4,936 |
| Deferred Rev, NC | CN¥127 | CN¥128 | CN¥129 | CN¥130 |
| Deferred Tax Liab, NC | CN¥190 | CN¥190 | CN¥189 | CN¥188 |
| Other NC Liab. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total NC Liab. | CN¥6,264 | CN¥6,216 | CN¥6,197 | CN¥5,269 |
| Other Liabilities | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Cap. Leases | CN¥0 | CN¥16 | CN¥13 | CN¥15 |
| Total Liabilities | CN¥10,528 | CN¥10,483 | CN¥11,120 | CN¥10,643 |
| Equity | – | – | – | – |
| Pref Stock | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Common Stock | CN¥8,831 | CN¥8,831 | CN¥8,831 | CN¥8,831 |
| Retained Earnings | CN¥9,575 | CN¥9,533 | CN¥9,490 | CN¥9,478 |
| AOCI | CN¥1,906 | CN¥993 | CN¥1,937 | CN¥0 |
| Other Equity | CN¥0 | CN¥0 | CN¥0 | CN¥1,139 |
| Total Equity | CN¥18,523 | CN¥18,491 | CN¥18,469 | CN¥18,626 |
| Supplemental Information | – | – | – | – |
| Minority Interest | CN¥243 | CN¥249 | CN¥256 | CN¥380 |
| Total Liab. & Tot. Equity | CN¥29,294 | CN¥29,223 | CN¥29,845 | CN¥29,650 |
| Net Debt | CN¥2,098 | CN¥1,359 | CN¥1,263 | CN¥290 |